Month: June 2021

MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) — Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the stress hormone cortisol, announced today that Joshua M. Murray has joined the company’s Board of Directors. Mr. Murray is currently Senior Vice President, Finance, Strategy and Investor Relations at Orca Bio, a privately held biotechnology company developing allogeneic cell therapies in blood, immune, and genetic diseases. Prior to joining Orca, Mr. Murray spent 15 years at Goldman Sachs, most recently as a Managing Director in the Investment Banking Division, where he advised a wide array of biotechnology and life sciences companies. He received an AB in History...

SAN DIEGO, June 10, 2021 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced its participation in the JMP Securities Life Sciences Conference. Troy Wilson, Ph.D., J.D., President and Chief Executive Officer, is scheduled to present in a virtual fireside chat at 3:00 p.m. ET / 12:00 p.m. PT on Thursday, June 17, 2021. A live audio webcast of the presentation will be available in the Investors section of Kura’s website at www.kuraoncology.com, with a replay available shortly after the live event. About Kura Oncology Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The Company’s pipeline...

BARRIE, Ontario, June 10, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced the results of matters voted on at its annual meeting of holders of common shares held on Wednesday, June 9, 2021 (the “Meeting”). The voting results for each of the matters presented at the Meeting are outlined below. There were 361 shareholders represented virtually or by proxy at the Meeting holding 65,230,720 common shares, representing 25.29% of MediPharm Labs total issued and outstanding common shares as at the record date for the Meeting. As the Meeting was held virtually, all resolutions were passed by a ballot vote. 1.   Election of...

Gilat chosen as sole provider to address most advanced present and future defense connectivity requirementsNet-Centric Warfare Enabled with Satellite CommunicationSuperior performance and efficiency in the battle fieldPETAH TIKVA, Israel, June 10, 2021 (GLOBE NEWSWIRE) — Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services announced that it was awarded a contract to supply satellite communication equipment for military usage. Gilat was chosen as the sole provider to address most advanced present and future defense connectivity requirements. Today’s net-centric warfare and the digital transformation have increased the importance of satellite-based communication solutions in the battlefield. Gilat’s advanced technology...

SAN FRANCISCO and TORONTO, June 10, 2021 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced that it has received commitments from the Company’s two largest shareholders to vote in favor of the special resolution to affect a consolidation of the Company’s common shares. As previously announced, Claritas will hold its Annual General and Special Meeting of Shareholders on June 17, 2021 (the “Annual Meeting”) to consider and vote on several matters, including a special resolution authorizing the board of directors of the Company (the “Board”) to affect a consolidation of all of the Company’s issued and outstanding Common Shares on the basis of one post consolidation Common Share for up to 20 pre-consolidation Common Shares (the “Consolidation”). The...

Any relief granted will be for the sole benefit of IPL shareholders BROOKFIELD, NEWS, June 10, 2021 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners L.P. (NYSE: BIP; TSX: BIP.UN), together with its institutional partners (collectively, “Brookfield Infrastructure”) has filed an application with the Alberta Securities Commission (the “ASC”) challenging the defensive tactics inappropriately employed by Inter Pipeline Ltd. (TSX: IPL) (“IPL”) and the special committee of its board of directors. Our application seeks, on behalf of all IPL shareholders, the elimination of the $350 million termination fee (the “Break Fee”), agreed to by IPL and its board of directors, which threatens to enrich Pembina Pipeline Corporation (“Pembina”) at the expense of IPL’s existing shareholders. This Break Fee was agreed in the face of a clearly...

An Emerging Markets Sponsored Commentary ORLANDO, Fla., June 10, 2021 (GLOBE NEWSWIRE) — Recent news from newly covered company FuelPositive Corporation (TSX.V: NHHH) (OTC: NHHHF) could be a significant breakthrough. When we say significant we are referring to the potential production of a fossil fuel replacing carbon-free fuel technology that is both highly efficient and good for the environment. For the record, FuelPositive is a Canadian-based growth stage company committed to providing commercially viable and sustainable clean energy solutions, including Carbon-Free Ammonia (NH3), for use across a broad spectrum of industries and applications. The existing ammonia market is massive, representing more than US$70 billion per year, and in its current production capacity, a major greenhouse gas emission contributor. If you’re unaware...

WARSAW, Ind., June 10, 2021 (GLOBE NEWSWIRE) — OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today the launch of its 6.5mm/7.3mm Slipped Capital Femoral Epiphysis (“SCFE”) Cannulated Screw system. The company previously received 510(k) clearance from the U.S. Food and Drug Administration (FDA), as expanded indications for its next generation Cannulated Screw System. The OrthoPediatrics 6.5mm/7.3mm SCFE system has been completely rethought and precisely designed. The system offers flexibility to treat pediatric specific SCFE injuries with fully threaded screws and partially threaded screws for common trauma indications. Unlike other systems on the market, the OP fully threaded SCFE screws are available in 2mm increments, providing...